Share Name Share Symbol Market Type Share ISIN Share Description
Centamin Plc LSE:CEY London Ordinary Share JE00B5TT1872 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00p -0.87% 113.70p 113.50p 113.70p 114.55p 112.75p 114.00p 651,574 08:45:38
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Mining 473.0 119.7 5.1 22.2 -

Centamin PLC Appointment of Non-Executive Director

25/03/2019 4:04pm

UK Regulatory (RNS & others)


RNS Number : 9318T

Centamin PLC

25 March 2019

 For immediate release     25 March 2019 

Centamin plc ("Centamin" or "the Company")


Appointment of Non-Executive Director

Centamin is pleased to announce the appointment of Dr. Sally Eyre, B.Sc., Ph.D., DIC, as an independent Non-Executive Director, effective 10 April 2019.

Dr. Eyre is a mining finance professional with extensive experience in global resource capital markets and mining operations. As a geologist, obtaining her doctoral degree in Economic Geology from the Royal School of Mines, Imperial College, London, Dr. Eyre brings strong technical balance to the existing Board composition.

Throughout Dr. Eyre's career, she has acquired substantial capital market, finance and directorate expertise. From 2011 to 2014, Dr. Eyre was President and Chief Executive Officer of TSX Venture Exchange listed Copper North Mining. Prior to this, from 2008 to 2011, she was an executive with Endeavour Financial, which transformed into the intermediate gold mining Company, Endeavour Mining. During this period of transformation, Dr. Eyre served as the President and Chief Executive Officer of Etruscan Resources and subsequently as Senior Vice President Operations, of Endeavour Mining.

Dr. Eyre currently holds two non-executive directorships: Adventus Zinc Corporation and Japan Gold Corporation. Adventus Zinc is a TSX Venture Exchange listed company. Dr. Eyre has been a Non-Executive Director since 2017, where she is the Chair of the Corporate Governance Committee and a member of the Audit Committee and Steering Committee. Japan Gold is a TSX Venture Exchange listed company. Dr. Eyre has been a Non-Executive Director since 2016, where she is the Chair of the Corporate Governance Committee and a member of the Audit Committee.

Following Dr. Eyre's appointment, the Centamin Board will comprise of nine members: the non-executive Chair, two Executives and six independent Non-Executives. This appointment is in accordance with the UK Corporate Governance Code and the Company's ongoing commitment to achieving the highest standards of corporate governance.

Josef El-Raghy, Chairman commented:

"We are delighted to be welcoming Sally to the Company. Her excellent technical skills and experience acquired throughout her career will be a valued addition to our existing diverse and multidisciplinary Board."

There are no further details that are required to be disclosed in respect of the appointment under LR9.6.13 of the UK FCA Listing Rules.

This announcement contains additional regulated information.

For more information, please visit the website or contact:

   Centamin plc                               Buchanan Communications 
   Andrew Pardey, Chief Executive Officer     Bobby Morse 
   Alexandra Carse, Investor Relations        Chris Judd 
   +44 (0) 7700 713 738                       + 44 (0) 20 7466 5000       

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

March 25, 2019 12:04 ET (16:04 GMT)

1 Year Centamin Chart

1 Year Centamin Chart

1 Month Centamin Chart

1 Month Centamin Chart
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190626 08:00:47